Ovarian Carcinosarcoma Overview
Learn About Ovarian Carcinosarcoma
- Ovarian carcinosarcoma
- MMMT of the ovary
- Malignant mixed Müllerian tumor of the ovary
- Malignant mixed mullerian tumor of the ovary
- Ovarian malignant mixed Müllerian tumor
- Ovarian malignant mixed epithelial mesenchymal tumor
Yale University
Alessandro Santin is an Obstetrics and Gynecologist and an Oncologist in New Haven, Connecticut. Dr. Santin is rated as an Elite provider by MediFind in the treatment of Ovarian Carcinosarcoma. His top areas of expertise are Ovarian Carcinosarcoma, Endometrial Cancer, Ovarian Cancer, Hysterectomy, and Salpingo-Oophorectomy.
Health First Medical Group LLC
Gulden Menderes is a Gynecologic Oncologist and an Oncologist in Melbourne, Florida. Dr. Menderes is rated as an Elite provider by MediFind in the treatment of Ovarian Carcinosarcoma. Her top areas of expertise are Ovarian Carcinosarcoma, Endometrial Cancer, Ovarian Cancer, Lymphadenectomy, and Hysterectomy. Dr. Menderes is currently accepting new patients.
Gloria Huang is a Gynecologic Oncologist and an Oncologist in New Haven, Connecticut. Dr. Huang is rated as an Elite provider by MediFind in the treatment of Ovarian Carcinosarcoma. Her top areas of expertise are Ovarian Carcinosarcoma, Ovarian Cancer, Endometrial Cancer, and Adult Soft Tissue Sarcoma.
Summary: This phase I trial tests the safety, side effects, and best dose of combination therapy with pelcitoclax (APG-1252) and cobimetinib in treating patients with ovarian and endometrial cancers that have come back after a period of improvement (recurrent). APG-1252 is a drug that inhibits activity of proteins that prevent cell death, leading to increased cell death and reduced cell growth. Cobimetinib...
Summary: This is a single center prospective observational study to characterize the immune landscape of newly diagnosed epithelial ovarian cancer (OC). Patients with newly diagnosed epithelial OC will be enrolled in 4 different cohorts: A) Newly diagnosed high grade serous or endometroid OC undergoing primary debulking surgery; B) Newly diagnosed high grade serous or endometroid OC undergoing neoadjuvant ...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center